Hallmarks of cardiovascular ageing

M Abdellatif, PP Rainer, S Sedej… - Nature Reviews …, 2023 - nature.com
Normal circulatory function is a key determinant of disease-free life expectancy (healthspan).
Indeed, pathologies affecting the cardiovascular system, which are growing in prevalence …

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …

G Mancia, R Kreutz, M Brunström, M Burnier… - Journal of …, 2023 - journals.lww.com
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

Sex differences in the renin-angiotensin-aldosterone system and its roles in hypertension, cardiovascular, and kidney diseases

SM Nwia, APO Leite, XC Li, JL Zhuo - Frontiers in Cardiovascular …, 2023 - frontiersin.org
Cardiovascular disease is a pathology that exhibits well-researched biological sex
differences, making it possible for physicians to tailor preventative and therapeutic …

OHDSI Standardized Vocabularies—a large-scale centralized reference ontology for international data harmonization

C Reich, A Ostropolets, P Ryan… - Journal of the …, 2024 - academic.oup.com
Abstract Importance The Observational Health Data Sciences and Informatics (OHDSI) is the
largest distributed data network in the world encompassing more than 331 data sources with …

[PDF][PDF] 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …

M Brunström, M Burnier… - Journal of …, 2023 - docred-strapi-cms-prod.s3.sa-east-1 …
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

Development of the TrAnsparent ReportinG of observational studies Emulating a Target trial (TARGET) guideline

HJ Hansford, AG Cashin, MD Jones, SA Swanson… - BMJ open, 2023 - bmjopen.bmj.com
Background Observational studies are increasingly used to inform health decision-making
when randomised trials are not feasible, ethical or timely. The target trial approach provides …

Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta …

M Esler, SE Kjeldsen, A Pathak, G Grassi, R Kreutz… - Blood …, 2022 - Taylor & Francis
Beta-blockers have solid documentation in preventing cardiovascular complications in the
treatment of hypertension; atenolol, metoprolol, oxprenolol and propranolol demonstrate …

β-blockers are not all the same: pharmacologic similarities and differences, potential combinations and clinical implications

S Taddei, N Tsabedze, RS Tan - Current Medical Research and …, 2024 - Taylor & Francis
Abstract β-blockers are a heterogeneous class, with individual agents distinguished by
selectivity for β1-vs. β2-and α-adrenoceptors, presence or absence of partial agonist activity …

[HTML][HTML] National Heart Center/Saudi Heart Association 2023 guidelines on the management of hypertension

W Alhabeeb, AA Tash, M Alshamiri… - Journal of the Saudi …, 2023 - ncbi.nlm.nih.gov
National Heart Center/Saudi Heart Association 2023 Guidelines on the Management of
Hypertension - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …

Analysis of dual combination therapies used in treatment of hypertension in a multinational cohort

Y Lu, M Van Zandt, Y Liu, J Li, X Wang… - JAMA network …, 2022 - jamanetwork.com
Importance More than 1 billion adults have hypertension globally, of whom 70% cannot
achieve their hypertension control goal with monotherapy alone. Data are lacking on clinical …